Table 5.
Covariate and subgroup
|
Number of included studies
|
Kappa value (95%CI)
|
P
value
|
Study design | 0.26 | ||
Retrospective | 7 | 0.78 (0.69, 0.85) | |
Prospective | 1 | 0.61 (0.45, 0.73) | |
Enrollment method | < 0.01 | ||
Consecutive | 7 | 0.73 (0.62, 0.80) | |
Selective | 1 | 0.94 (0.89, 0.97) | |
LI-RADS version | 0.66 | ||
2016 | 4 | 0.74 (0.58, 0.85) | |
2017 | 4 | 0.78 (0.62, 0.88) | |
Number of interobservers | < 0.01 | ||
2 | 7 | 0.79 (0.71, 0.85) | |
3 | 1 | 0.39 (0.14, 0.59) | |
Number of US systems | 0.93 | ||
1 | 4 | 0.77 (0.65, 0.85) | |
> 1 | 4 | 0.76 (0.51, 0.89) | |
Race of patients | < 0.01 | ||
Westerners | 1 | 0.79 (0.71, 0.85) | |
Easterners | 7 | 0.39 (0.14, 0.59) | |
Number of FLLs | 0.16 | ||
< 100 | 5 | 0.72 (0.48, 0.86) | |
> 100 | 3 | 0.82 (0.76, 0.87) | |
Reference standard | 0.58 | ||
Pathology | 1 | 0.69 (0.52, 0.81) | |
Pathology and SCRS | 7 | 0.77 (0.67, 0.84) |
FLL: Focal hepatic lesion; LI-RADS: Liver Imaging Reporting and Data System; SCRS: Synthesized clinical reference standard; US: Ultrasound.